IBM taps RFID for pharma industry

IBM unveiled a radio frequency identification (RFID) system for tracking and tracing of pharmaceuticals.

The system makes it more difficult for counterfeit drugs to get to market, protecting consumers by helping ensure the drugs they receive match the prescription from their physician.

With nearly 8 percent of the world's prescriptions proving counterfeit each year, the US Food and Drug Administration has cited RFID as the most promising technology to ensure that the medicine in the bottle is exactly what the doctor ordered.

The global pharmaceutical supply chain is highly complicated. From the point of manufacture to the point of sale, drugs can change hands as many as ten times. IBM's software and services are designed to help manufacturers protect product from theft and fraud and avoid replacement costs for product recalls and tarnished brand value.

The IBM RFID system for pharmaceutical track and trace uses blended RFID software and services to automatically capture and track the movement of drugs through the supply chain. RFID tags are embedded on products at the unit, case and pallet level and authenticate the product from manufacturer to wholesalers to hospitals and pharmacies. Each tag contains a unique identifier -- like a license plate -- that can be linked back to descriptive product information such as dosage and strength, lot number, manufacturer and expiration date.

"We hold the security of the nation's drug supply as a top priority and have taken several leadership steps to ensure a safe and secure supply chain," said Renard Jackson, executive vice president for Cardinal Health. "As part of a multi-pronged approach, RFID is a promising technology that has the potential to add an additional layer of security and improve efficiency across the entire supply chain, which is why we have partnered with leaders like IBM in a pilot program to determine its feasibility and effectiveness in a real-world setting."

In addition to consumer protection, the IBM-developed RFID system helps manufacturers and distributors improve performance by reducing the cash tied up in inventory, targeting recalls and enabling faster response to market demand.

"IBM's extensive experience with RFID has demonstrated that this technology has unique capabilities to offer in helping protect drugs from tampering," said Paul Chang, RFID/Pharma Executive, IBM. "And in an industry that lives depend on, IBM is leading the way to a safer, more secure supply chain."

The IBM RFID system for pharmaceutical track and trace is based on the IBM WebSphere software platform and an architecture that allows clients to reuse existing assets, thereby building new applications quickly and at a lower cost for development.

IBM provides RFID systems for hundreds of the world's leading companies, as well as middle-market and growing companies. This offering is based on a definable, repeatable methodology that enables streamlined service delivery.

For further information, please visit:
www.ibm.com/healthcare

Most Popular Now

AI in Personalized Cancer Medicine: New …

The application of AI in precision oncology has so far been largely confined to the development of new drugs and had only limited impact on the personalisation of therapies. New...

AI can Predict Brain Cancer Patients…

Artificial Intelligence (AI) can predict whether adult patients with brain cancer will survive more than eight months after receiving radiotherapy treatment. The use of the AI to successfully predict patient outcomes...

Max Planck Institute for Informatics and…

The Max Planck Institute for Informatics and Google deepen their strategic research partnership. With additional financial support from the U.S. IT company, the "Saarbr├╝cken Research Center for Visual Computing, Interaction...

JMIR Medical Informatics Invites Submiss…

JMIR Publications has announced a new section titled, "AI Language Models in Health Care" in JMIR Medical Informatics. This leading peer-reviewed journal is indexed in PubMed and has a unique...

Paper Calls for Patient-First Regulation…

Ever wonder if the latest and greatest artificial intelligence (AI) tool you read about in the morning paper is going to save your life? A new study published in JAMA...

Could ChatGPT Help or Hurt Scientific Re…

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short...

Evaluating the Performance of AI-Based L…

A new study evaluates an artificial intelligence (AI)-based algorithm for autocontouring prior to radiotherapy in head and neck cancer. Manual contouring to pinpoint the area of treatment requires significant time...

Making AI a Partner in Neuroscientific D…

The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence...

Chapman Scientists Code ChatGPT to Desig…

Generative artificial intelligence platforms, from ChatGPT to Midjourney, grabbed headlines in 2023. But GenAI can do more than create collaged images and help write emails - it can also design...

DMEA nova Award: Wanted - Visionary Solu…

9 - 11 April 2024, Berlin, Germany. The DMEA nova Award is being presented at DMEA 2024 for the first time. The award honours a digital health startup for an outstanding...

New Digital Therapy Reduces Anxiety and …

A therapist-guided digital cognitive behavioural therapy reduced distress in 89 per cent of participants living with long-term physical health conditions, a new King's College London study finds. Researchers at the Institute...

Europe's Digital Health Industry Me…

9 - 11 April 2024, Berlin, Germany. In just over two months, from 9 to 11 April 2024, DMEA, Europe's leading event for digitalisation of healthcare, will gather digital health experts...